NRIX Earnings Nurix Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-02-28 | -0.79 | 2026-04-08 | 10-Q |
| FY 2025 | 2025-11-30 | -3.05 | 2026-01-28 | 10-K |
| Q3 2025 | 2025-08-31 | -2.22 | 2025-10-09 | 10-Q |
| Q2 2025 | 2025-05-31 | -1.19 | 2025-07-09 | 10-Q |
| Q1 2026 | 2025-02-28 | -0.67 | 2026-04-08 | 10-Q |
| FY 2025 | 2024-11-30 | -2.88 | 2026-01-28 | 10-K |
| Q3 2025 | 2024-08-31 | -2.13 | 2025-10-09 | 10-Q |
| Q2 2025 | 2024-05-31 | -1.47 | 2025-07-09 | 10-Q |
| Q1 2025 | 2024-02-29 | -0.76 | 2025-04-08 | 10-Q |
| FY 2025 | 2023-11-30 | -2.65 | 2026-01-28 | 10-K |
| Q3 2024 | 2023-08-31 | -1.88 | 2024-10-11 | 10-Q |
| Q2 2024 | 2023-05-31 | -1.20 | 2024-07-11 | 10-Q |
| Q1 2024 | 2023-02-28 | -0.75 | 2024-04-10 | 10-Q |
| FY 2024 | 2022-11-30 | -3.71 | 2025-01-28 | 10-K |
| Q3 2023 | 2022-08-31 | -2.85 | 2023-10-12 | 10-Q |
| Q2 2023 | 2022-05-31 | -1.96 | 2023-07-13 | 10-Q |
| Q1 2023 | 2022-02-28 | -0.95 | 2023-04-13 | 10-Q |
| FY 2022 | 2021-11-30 | -2.73 | 2023-02-09 | 10-K |
| Q3 2022 | 2021-08-31 | -1.88 | 2022-10-06 | 10-Q |
| Q2 2022 | 2021-05-31 | -1.23 | 2022-07-07 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.